Showing results (761-770 of 1,169) with videos related to

Sort By:
Pageof 117
Frontiers in Oncology|August 18, 2023
Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinomaXiaogang Li, Zheng Gao, Jiafeng Chen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 8, 2023
ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic TelangiectasiaXingyan Zhou, Jenna C Pucel, Aya Nomura-Kitabayashi, et al.
Cancer Science|June 2, 2026
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCAChengqiang Sun, Zheng Gao, Enfu Dong, et al.
American Journal of Cancer Research|June 21, 2019
eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulationBisi Miao, Chuanyuan Wei, Zijun Qiao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 10, 2007
[Therapeutic effects of hepatic resection in liver metastasis of colorectal cancer]Jian-Min Xu, Yun-Shi Zhong, Jia Fan, et al.
Theranostics|September 28, 2022
ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffoldWenjing Yang, Beili Wang, Qian Yu, et al.
Future Oncology (London, England)|November 16, 2019
Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgroundsMin-Cheng Yu, Ji-Xiang Liu, Xiao-Lu Ma, et al.
The Oncologist|September 17, 2014
Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH studyShukui Qin, Ying Cheng, Jun Liang, et al.
Clinical and Translational Medicine|December 30, 2020
CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signalingBo Hu, Yang Xu, Yuan-Cheng Li, et al.
Cancer Research|July 10, 2012
BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinomaLixing Zhang, Hefen Sun, Fangyu Zhao, et al.
Pageof 117